Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-07-17
1988-08-30
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
549523, A61K 3155, C07D40104, C07D40106, C07D40114, C07D40304, C07D40306, C07D40314, C07D41304, C07D41306, C07D41314, C07D41704, C07D41706, C07D41714
Patent
active
047677562
ABSTRACT:
Benzazepine derivatives useful, for example, as cardiovascular agents, are disclosed. These compounds have the general formula ##STR1## and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 3312691 (1967-04-01), Wertner et al.
patent: 3330823 (1967-07-01), Bernstein et al.
patent: 3562257 (1971-02-01), Kugita et al.
patent: 3748321 (1973-07-01), Krapcho
Chemical Abstracts, vol. 106 (1987) Abstracting European Patent Application EP 205,334, published Dec. 17, 1985.
Reaction of 3-Phenylglycidic Esters IV.sup.1. Reaction of Methyl
3-(4-Methoxyphenyl)glycidate with 2-Nitrophenol and Synthesis of 1,5-Benzoxazepine Derivatives, Hashiyama et al. (Chem. Pharm. Bull.)
Das Jagabandhu
Floyd David M.
Bond Robert T.
E. R. Squibb & Sons Inc.
Furman Jr. Theodore R.
Levinson Lawrence S.
LandOfFree
3-substituted benzazepines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-substituted benzazepines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted benzazepines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2088389